Utility of systemic immune-inflammation index as a serum biomarker to differentiate between complicated and simple para-pneumonic effusion
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The systemic immune-inflammation index (SII) is a novel inflammatory biomarker. Simple and complicated para-pneumonic effusion (PPE) are two significant complications of pneumonia. We evaluated the efficacy of the SII to differentiate between the two. Records of all children up to 18 years of age admitted between April 2019 and September 2022 and diagnosed with simple or complicated PPE were retrospectively evaluated. SII and other biomarkers were compared between both groups. Receiver operating characteristics with the Youden index were used to estimate the discriminative value of SII. 50 children were enrolled with a median (interquartile range) age of 81.5 (36.7, 133.5) months; 31 (62%) were male. 31 (62%) had complicated PPE, and 19 (38%) had simple PPE. SII was significantly higher in complicated PPE (p=0.007). Good areas under the curve were found for C-reactive protein (0.771) and SII (0.736) to differentiate complicated from simple PPE. The best cut-off value for SII to differentiate complicated PPE from simple PPE was 1557×103μL, with a sensitivity of 82.4% and specificity of 57.6%. SII can be used as a screening tool to differentiate between complicated and simple PPE at the time of presentation.
Ethics Approval
The study protocol was approved by the Ethical Review Committee of the All India Institute of Medical Sciences, Jodhpur No. AIIMS/IEC/2019/1766.How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.